Evaluating neurometabolic networks for predicting survival in colorectal cancer
An Observational Study on the Prognostic Value of Neurometabolic Networks in Colorectal Cancer
This study is testing a new way to predict survival in colorectal cancer patients by looking at how different networks in the body interact and affect outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 213 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | The First Affiliated Hospital of Zhengzhou University Academic / other |
| Locations | 1 site (Henan, Henan) |
| Trial ID | NCT06930586 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the prognostic value of neurometabolic networks in predicting overall survival for patients with colorectal cancer (CRC). It will evaluate the area under the curve (AUC) of a model called BRIDGE and compare its predictive capabilities against existing clinical prediction models. The study focuses on understanding the complex interactions within the gastrointestinal ecosystem and their implications for tumorigenesis and patient outcomes. By adopting a systemic perspective, the research seeks to improve early detection and management strategies for CRC.
Who should consider this trial
Good fit: Ideal candidates for this study are male and female patients aged 18 and older who have been diagnosed with rectal cancer.
Not a fit: Patients with colorectal cancer who are not eligible due to age or diagnosis may not receive any benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved survival predictions for colorectal cancer patients, enabling more personalized treatment approaches.
How similar studies have performed: Other studies have shown promise in using neurometabolic networks for cancer prognosis, but this specific approach is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Male/Female subjects with rectal cancer of at least 18 years of age will be enrolled in this trial.
Where this trial is running
Henan, Henan
- Pet/ct — Henan, Henan, China (Recruiting)
Study contacts
- Study coordinator: Yujie Bai
- Email: baiyujie1010@163.com
- Phone: +8617803883306
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.